Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Girard

Showing results (181-190 of 396) with videos related to

Pageof 40
Sort By:
Joint Bone Spine|July 13, 2023
Peripheral but not axial muscle mass is associated with early mortality in bone metastatic lung cancer patients at diagnosisCélia Dandache, Cyrille B Confavreux, Antoine Gavoille, et al.
Joint Bone Spine|April 10, 2018
Bone metastases from lung cancer: A paradigm for multidisciplinary onco-rheumatology managementCyrille B Confavreux, Jean-Baptiste Pialat, Aurélie Bellière, et al.
Plos One|March 22, 2019
Activation of the mTOR/ Akt pathway in thymic epithelial cells derived from thymomasJean-Michel Maury, Claire Merveilleux du Vignaux, Gabrielle Drevet, et al.
Cancers|May 16, 2023
Total Metabolic Tumor Volume on 18F-FDG PET/CT Is a Useful Prognostic Biomarker for Patients with Extensive Small-Cell Lung Cancer Undergoing First-Line Chemo-ImmunotherapyJulia Grambow-Velilla, Romain-David Seban, Kader Chouahnia, et al.
Cancers|October 27, 2022
Subtotal Pleurectomy with Intrathoracic Chemo Hyperthermia (HITHOC) for IVa Thymomas: De Novo Versus Recurrent Pleural DiseaseBenjamin Chappuy, Gabrielle Drevet, Hugo Clermidy, et al.
Bulletin Du Cancer|August 6, 2009
[Confidentiality in medical practice: tell no one]Sébastien Couraud, Dominique Arpin, Maurice Perol, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Real-life effectiveness of erlotinib as second-line treatment of stage IIIB/IV squamous non-small cell lung cancer: Results of the PEPiTA observational studyIsabelle Monnet, Clarisse Audigier-Valette, Nicolas Girard, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Intra-Thoracic Chemo-Hyperthermia for pleural recurrence of thymomaJean Michel Maury, Nicolas Girard, Mayeul Tabutin, et al.
Archives of Cardiovascular Diseases|July 30, 2025
Cardiovascular safety of a standardized outpatient triage and diagnostic approach for suspected cardiovascular immune-related adverse events of immune checkpoint inhibitorsFrancesco Cribari, Imen Hamdi, Soledad Henriquez, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2021
Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapyRomain-David Seban, Jean-Baptiste Assié, Etienne Giroux-Leprieur, et al.
Pageof 40

Showing results (181-190 of 396) with videos related to

Sort By:
Pageof 40
Joint Bone Spine|July 13, 2023
Peripheral but not axial muscle mass is associated with early mortality in bone metastatic lung cancer patients at diagnosisCélia Dandache, Cyrille B Confavreux, Antoine Gavoille, et al.
Joint Bone Spine|April 10, 2018
Bone metastases from lung cancer: A paradigm for multidisciplinary onco-rheumatology managementCyrille B Confavreux, Jean-Baptiste Pialat, Aurélie Bellière, et al.
Plos One|March 22, 2019
Activation of the mTOR/ Akt pathway in thymic epithelial cells derived from thymomasJean-Michel Maury, Claire Merveilleux du Vignaux, Gabrielle Drevet, et al.
Cancers|May 16, 2023
Total Metabolic Tumor Volume on 18F-FDG PET/CT Is a Useful Prognostic Biomarker for Patients with Extensive Small-Cell Lung Cancer Undergoing First-Line Chemo-ImmunotherapyJulia Grambow-Velilla, Romain-David Seban, Kader Chouahnia, et al.
Cancers|October 27, 2022
Subtotal Pleurectomy with Intrathoracic Chemo Hyperthermia (HITHOC) for IVa Thymomas: De Novo Versus Recurrent Pleural DiseaseBenjamin Chappuy, Gabrielle Drevet, Hugo Clermidy, et al.
Bulletin Du Cancer|August 6, 2009
[Confidentiality in medical practice: tell no one]Sébastien Couraud, Dominique Arpin, Maurice Perol, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Real-life effectiveness of erlotinib as second-line treatment of stage IIIB/IV squamous non-small cell lung cancer: Results of the PEPiTA observational studyIsabelle Monnet, Clarisse Audigier-Valette, Nicolas Girard, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Intra-Thoracic Chemo-Hyperthermia for pleural recurrence of thymomaJean Michel Maury, Nicolas Girard, Mayeul Tabutin, et al.
Archives of Cardiovascular Diseases|July 30, 2025
Cardiovascular safety of a standardized outpatient triage and diagnostic approach for suspected cardiovascular immune-related adverse events of immune checkpoint inhibitorsFrancesco Cribari, Imen Hamdi, Soledad Henriquez, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2021
Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapyRomain-David Seban, Jean-Baptiste Assié, Etienne Giroux-Leprieur, et al.
Pageof 40